Grace

Bryson

Regional Regulatory Affairs and Quality Assurance Executive

PSI South Africa

Grace Bryson has been with PSI South Africa since January 2018 and acts as the Regional Regulatory Affairs and Quality Assurance Executive, responsible for the oversight and coordination of product registration and compliance for the Southern Africa and East Africa regions.

Grace is a qualified pharmacist, registered with the South African Pharmacy Council. In 2010, she completed a Bachelor of Pharmacy Honours qualification from Rhodes University, South Africa. Following her graduation, she completed her prerequisite year of pharmacy internship in a private retail Pharmacy environment and went on to complete her prerequisite year of pharmacy community service at a rural South African public sector hospital, gaining experience within the hospital’s HIV, TB and circumcision clinics.

Ms. Bryson’s career in the pharmaceutical industry truly began when she contracted with UTi Pharma (now known as DSV) as a Quality Assurance (QA) Receiving Pharmacist. She later began a full-time QA position at UTi’s cold chain facility as the Acting Responsible Pharmacist.

In 2014, Ms. Bryson began working at Mylan Pharmaceuticals (Pty) Ltd. as a QA Pharmacist and was nominated for the Mylan Business Partner of the Year Award for her contributions to the company in 2015. In 2016 she was promoted to head the Quality Assurance department and to sit on the company’s local Executive Committee, reporting directly to both the Country Head as well as the Senior Director of Regional Quality for Europe and coordinating a team of four.

In 2017 Ms. Bryson completed a Post Graduate Diploma in Management course through Gordon’s Institute of Business Science.

Ms. Bryson has a thorough understanding of the pharmaceutical industry. During her time as a QA pharmacist, she worked with pharmacovigilance and regulatory teams, requiring a sound knowledge of both areas in order to ensure compliance. Her previous work experience affords her a well-rounded understanding of the entire pharmaceutical supply chain, from raw material manufacture through to registration, finished product manufacturing, warehousing, distribution, dispensing and finally patient use in both the private and public sectors.

Latest
Updates

Discover what's happening at PSI

In Memoriam to Bill Gates, Sr.

By Karl Hofmann, President & CEO, PSI  Let me add our voices to those who have paid tribute to Bill Gates, Sr. His remarkable contributions to the work of

+ Read More

Youth Contraceptive Programming: Learning from a Mid-Term Evaluation

As a learning project, PSI’s flagship adolescent sexual and reproductive health program, Adolescents 360 (A360) used its external 2018 mid-term evaluation (MTE) to support corrections

+ Read More

Infected and Affected: The Indirect Consequences of COVID-19 in Central America

By Jennifer Wheeler, PSI Deputy Director, Research, Paola Letona, PSI Evidence Regional Director, LAC, and Sussy Lungo, Regional Executive Director, Asociación PASMO “When you are

+ Read More

Five Market Indicators that Signal the Hormonal IUS will take off

By Kendal Danna, PSI Technical Advisor, Reproductive Health  In 2017, with USAID support, PSI began piloting the introduction of the hormonal Intrauterine System (IUS), also

+ Read More

HIVST for Key populations: Experiences from West Africa, Asia and Southern Africa

More than four decades into the HIV epidemic, an estimated 21% of people with HIV, more than 8.1 million people, remain undiagnosed. HIV self-testing is

+ Read More

In Memoriam of Hildah Mbaya

By Karl Hofmann, President & CEO, Population Services International PSI is extremely sad to report the untimely death of our Country Representative in South Sudan, Hildah

+ Read More